Black Rose Industries Limited · BSE:BLACKROSE
Black Rose Industries — FY2026 Earnings Presentation
14 slides from Black Rose Industries's earnings presentation, May 22, 2026
Slide 1: FY 2025-26 Earnings Webinar
FY 2025-26 EARNINGS WEBINAR May 22, 2026 BLACK ROSE INDUSTRIES LIMITED August 24, 2021
Slide 2: Disclaimer
FY2025-26 EARNINGS WEBINAR Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by BLACK ROSE INDUSTRIES LIMITED (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to pur
Slide 3: Business presence of Black Rose
FY2025-26 EARNINGS WEBINAR Business presence of Black Rose Acrylamide liquid – Polyacrylamide solid - 10,000 MTPA 32,000 MTPA (in R&D) Chemical (20,000 MTPA for merchant distribution sales and 12,000 MTPA for Chemical captive requirement) manufacturing N-methylol acrylamide Import and distribution o
Slide 4: Financials – Profit & Loss (Standalone & Consolidated)
FY2025-26 EARNINGS WEBINAR Financials – Profit & Loss (Standalone & Consolidated) INR. in millions STANDALONE STANDALONE CONSOLIDATED Particulars Q4 FY26 Q3 FY26 Change % YE FY26 YE FY25# Change % YE FY26 YE FY25 Change % Revenue from operations 1047.79 758.62 38.12% 3258.38 3406.85 -4.36% 3258.52 3
Slide 5: Financials – Balance Sheet (Standalone & Consolidated)
FY2025-26 EARNINGS WEBINAR Financials – Balance Sheet (Standalone & Consolidated) INR in millions STANDALONE CONSOLIDATED All ratios on basis of Standalone figures Particulars YE FY26 YE FY25 YE FY26 YE FY25 Return on Equity (%) Sources of Funds 14.00% 13.90% Equity Share Capital 51.0 51.0 51.0 51.0
Slide 6: Financials – (Standalone)
FY2025-26 EARNINGS WEBINAR Financials – (Standalone) Total revenue and EBITDA Highlights INR in millions 3,500 3,407 400 • Resilient performance driven by strong manufacturing growth 3,258 R 3,250 E E 350 B 354 V 327 I • Volume growth in distribution offset by E N 3,000 T chemical price correction D
Slide 7: Financials – Revenue and geographic mix
FY2025-26 EARNINGS WEBINAR Financials – Revenue and geographic mix 3% 1% MANUFACTURING 27% 35% DISTRIBUTION 70% 64% OTHERS YE FY25 YE FY26 15% EXPORTS 24% LOCAL 77% 85% Figures rounded off to closest unit percentage 7
Slide 8: Financials - Distribution
FY2025-26 EARNINGS WEBINAR Financials - Distribution Total distribution revenue and EBITDA Highlights INR in millions • Volume growth driven by domestic demand 2500 2431 250 • Price decline impacted overall revenues 2091 R 2000 210 200 • Stock-and-sales model boosted Q4 growth E E B amid middle-east
Slide 9: Financials - Manufacturing
FY2025-26 EARNINGS WEBINAR Financials - Manufacturing Total manufacturing revenue and EBITDA Highlights INR in millions • Increase in volumes for both acrylamide 1200 1141 400 liquid and NMA 948 900 300 • New customer addition and focus on exports drive growth R E E B V 251 E 600 200 I • Cost effici
Slide 10: Acrylonitrile – Acrylamide Price Trend
FY2025-26 EARNINGS WEBINAR Acrylonitrile – Acrylamide Price Trend 1600 1510 65 1400 1249 1215 1116 1350 1200 1128 1140 1090 1068 1110 1088 1105 1100 1134 1000 1086 1080 1073 1039 1031 1011 50 1013 ACN Price USD/MT 996 1033 1046 800 600 35 400 200 60 58 62 59 58 59 59 58 58 58 56 63 0 20 April'25 May
Slide 11: Outlook for the current quarter: Chemical distribution, and manufacturing
FY2025-26 EARNINGS WEBINAR Outlook for the current quarter: Chemical distribution, and manufacturing Chemical distribution Focus on new product additions and expanding end-user customer base Higher prices to drive overall revenue Near-term demand may remain subdued in Q1 due to global uncertai
Slide 12: Outlook for the current quarter: Chemical distribution, and manufacturing
FY2025-26 EARNINGS WEBINAR Outlook for the current quarter: Chemical distribution, and manufacturing Acrylamide liquid and solid N-methylol acrylamide (NMA) Expect domestic demand to pick up in second half Expected to remain stable Focus on new customer additions Focus on acrylamide liquid e
Slide 13: Ongoing and Upcoming Projects
FY2025-26 EARNINGS WEBINAR Outlook for the current quarter: Chemical distribution, and manufacturing Ongoing and Upcoming Projects PAM solid project advanced to piloting New downstream acrylamide products under development Specialty amines project decision expected during the year Ongoing in
Slide 14: Contact
FY2025-26 EARNINGS WEBINAR Contact Mr. Ambarish Daga Executive Director & Investor Relationship Officer Head office 145/A, Mittal Tower Nariman Point, Mumbai 400 021, India Call +91-22-4333-7200 Mail to investor@blackrosechemicals.com